Roivant Sciences (ROIV) Stock Forecast & Price Target

ROIV price $37.69 +0.57 +1.55%

Ticker
ROIV
Price
$37.69
Change
+0.57 +1.55%
Market cap ?
$27.22B
P/E ?
-97.66
Forward P/E ?
28.17
Dividend yield ?
0.00%
Beta ?
1.10
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
35
Value
36
Quality
30
Growth
38

Stocklytics score rationale: value 36, quality 30, growth 38.

Financials

2019202020212022202320242025
6768900023795000552860003153000032713000290530008260000

Roivant Sciences Ltd. is a biopharmaceutical and healthcare technology company dedicated to discovering and advancing innovative therapeutic drugs. The firm's development pipeline targets a broad spectrum of diseases, including various forms of solid tumors and oncologic malignancies, hematological disorders like sickle cell disease and warm autoimmune hemolytic anemia, as well as rare conditions such as…

Fair value

ROIV fair value $34.36. Price $37.69. Price is 10% above fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Compare ROIV

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-09—-0.37—3.74M
2026-08-06-0.33-0.301.44M2.06M
2026-05-20-0.28-0.292.52M3.41M
2026-02-06-0.24-0.302.00M5.08M
2025-11-10-0.20-0.321.57M5.62M
2025-08-11-0.25-0.252.17M7.30M
2025-05-29-0.29-0.267.57M54.07M
2025-02-10-0.23-0.259.02M5.00M
2024-11-12-0.29-0.254.47M45.92M
2024-08-080.12-0.2455.13M30.72M
2024-05-30-0.23-0.2628.93M31.01M
2024-02-13-0.21-0.3137.14M31.77M
2023-11-13-0.26-0.2837.10M27.11M
2023-08-14-0.38-0.3021.62M24.49M
2023-06-28-0.20-0.4127.38M18.17M
2023-02-13-0.49-0.3617.05M14.78M
2022-11-14-0.42-0.4112.53M5.70M
2022-08-15-0.48-0.304.32M7.18M
2022-06-28-0.39-0.259.22M13.35M
2022-02-14-0.41-0.2324.34M9.87M
2021-11-15-0.26-0.4513.99M7.22M
2021-09-21————
2021-08-10————

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-23Oren IlanBuy810——
2026-10-23Epperly Melissa B,Buy513——
2026-10-23Epperly Melissa B,Sell116$36.494.23K
2026-10-23MOMTAZEE JAMES CBuy383——
2026-10-23MOMTAZEE JAMES CSell77$36.492.81K
2026-10-20Venker EricSell185.86K$35.096.52M
2026-10-20Venker EricSell14.14K$35.42500.98K
2026-10-16Sukhatme MayukhSell19.98K$33.53669.80K
2026-10-16Gline MatthewSell34.64K$33.531.16M
2026-10-01Epperly Melissa B,Sell17.75K$4.4679.17K
2026-10-01Epperly Melissa B,Buy17.75K$4.4679.17K
2026-10-01Epperly Melissa B,Sell16.85K$36.08607.95K
2026-10-01Epperly Melissa B,Sell900$36.5732.91K
2026-09-30Gline MatthewSell76.17K$36.572.79M
2026-09-30Torti FrankBuy40.31K$36.571.47M
2026-09-30Sukhatme MayukhSell46.88K$36.571.71M
2026-09-30Venker EricSell200.00K$3.85770.00K
2026-09-30Venker EricBuy200.00K$3.85770.00K
2026-09-30Venker EricSell200.00K$36.627.32M
2026-09-20Humes JenniferSell3.88K$39.77154.31K
2026-09-20Pulik RichardSell2.13K$39.7784.67K
2026-09-16MANCHESTER KEITH SBuy5.05K——
2026-09-16MANCHESTER KEITH SBuy10.53K$39.57416.71K
2026-09-16Gold Daniel AllenBuy5.05K——
2026-09-16Gold Daniel AllenBuy10.53K$39.57416.71K
2026-09-16Oren IlanBuy5.05K——
2026-09-16Oren IlanBuy10.53K$39.57416.71K
2026-09-16MOMTAZEE JAMES CBuy5.05K——
2026-09-16MOMTAZEE JAMES CBuy10.53K$39.57416.71K
2026-09-16Fitzgerald MeghanBuy5.05K——
2026-09-16Fitzgerald MeghanBuy10.53K$39.57416.71K
2026-09-16Epperly Melissa B,Buy5.05K——
2026-09-16Epperly Melissa B,Buy10.53K$39.57416.71K
2026-09-15Epperly Melissa B,Sell4.34K$39.65172.00K
2026-09-15Epperly Melissa B,Sell600$40.3824.23K
2026-09-15Fitzgerald MeghanSell4.71K$39.68186.97K
2026-09-15Fitzgerald MeghanSell400$40.4516.18K
2026-09-10Gold Daniel AllenSell5.13K$40.94210.15K
2026-09-10Oren IlanSell2.38K$40.9497.36K
2026-09-10Epperly Melissa B,Sell2.18K$40.9489.21K
2026-09-10Fitzgerald MeghanSell1.74K$40.9471.36K
2026-09-10MOMTAZEE JAMES CSell2.90K$40.94118.93K
2026-09-08Fitzgerald MeghanBuy20.00K$8.80176.00K
2026-09-08Fitzgerald MeghanSell20.00K$39.90798.00K
2026-09-08Fitzgerald MeghanSell20.00K$8.80176.00K
2026-08-28Venker EricSell200.00K$3.85770.00K
2026-08-28Venker EricBuy200.00K$3.85770.00K
2026-08-28Venker EricSell166.18K$35.635.92M
2026-08-28Venker EricSell33.82K$36.441.23M
2026-08-21Sukhatme MayukhBuy144.76K$3.85557.31K
2026-08-21Sukhatme MayukhSell144.76K$36.485.28M
2026-08-21Sukhatme MayukhSell144.76K$3.85557.31K
2026-08-20Pulik RichardSell5.75K$36.84211.79K
2026-08-20Venker EricSell13.91K$36.84512.41K
2026-08-20Sukhatme MayukhBuy17.52K$3.8567.45K
2026-08-20Sukhatme MayukhSell17.52K$37.30653.46K
2026-08-20Sukhatme MayukhSell17.52K$3.8567.45K
2026-08-19Sukhatme MayukhBuy172.90K$3.85665.66K
2026-08-19Sukhatme MayukhSell172.90K$37.176.43M
2026-08-19Sukhatme MayukhSell172.90K$3.85665.66K
2026-08-18Sukhatme MayukhBuy105.14K$3.85404.79K
2026-08-18Sukhatme MayukhBuy31.80K$3.85122.43K
2026-08-18Sukhatme MayukhSell105.14K$36.593.85M
2026-08-18Sukhatme MayukhSell31.80K$37.181.18M
2026-08-18Sukhatme MayukhSell136.94K$3.85527.23K
2026-08-17Sukhatme MayukhBuy284.71K$3.851.10M
2026-08-17Sukhatme MayukhSell284.71K$36.2510.32M
2026-08-17Sukhatme MayukhSell284.71K$3.851.10M
2026-08-14Sukhatme MayukhBuy243.18K$3.85936.23K
2026-08-14Sukhatme MayukhSell243.18K$36.238.81M
2026-08-14Sukhatme MayukhSell243.18K$3.85936.23K
2026-07-27Venker EricSell200.00K$3.85770.00K
2026-07-27Venker EricBuy200.00K$3.85770.00K
2026-07-27Venker EricSell200.00K$34.956.99M
2026-07-17MOMTAZEE JAMES CBuy405——
2026-07-17Epperly Melissa B,Buy543——
2026-07-17Oren IlanBuy775——
2026-06-30Gline MatthewSell76.17K$35.392.70M
2026-06-30Fitzgerald MeghanBuy10.00K$8.8088.00K
2026-06-30Fitzgerald MeghanSell10.00K$34.90349.00K
2026-06-30Fitzgerald MeghanSell10.00K$8.8088.00K
2026-06-30Torti FrankSell40.31K$35.391.43M
2026-06-30Sukhatme MayukhSell46.88K$35.391.66M
2026-06-30MANCHESTER KEITH SSell12.38K$35.28436.77K
2026-06-30MANCHESTER KEITH SSell200.00K$35.457.09M
2026-06-30Gold Daniel AllenSell12.38K$35.28436.77K
2026-06-30QVT Financial LPSell12.38K$35.28436.77K
2026-06-29Epperly Melissa B,Sell17.75K$4.4679.17K
2026-06-29Epperly Melissa B,Buy17.75K$4.4679.17K
2026-06-29Epperly Melissa B,Sell15.00K$34.32514.87K
2026-06-29Epperly Melissa B,Sell2.75K$34.7195.38K
2026-06-29MANCHESTER KEITH SSell200.00K$34.446.89M
2026-06-29MANCHESTER KEITH SSell600.00K$34.5920.75M
2026-06-29Gold Daniel AllenSell200.00K$34.446.89M
2026-06-29Gold Daniel AllenSell600.00K$34.5920.75M
2026-06-29QVT Financial LPSell200.00K$34.446.89M
2026-06-29QVT Financial LPSell600.00K$34.5920.75M
2026-06-26MANCHESTER KEITH SSell300.78K$33.9210.20M
2026-06-26MANCHESTER KEITH SSell325.00K$34.0711.07M
2026-06-26Gold Daniel AllenSell300.78K$33.9210.20M

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 519, holders +51 vs prior quarter. Ownership 77.77%.

HolderSharesChangeChange %Value
FMR LLC81.02M3.04M+3.90%2.87B
BLACKROCK, INC.48.24M3.98M+9.00%1.71B
MORGAN STANLEY42.59M-9.24M-17.82%1.51B
QVT FINANCIAL LP23.72M-1.44M-5.72%839.56M
VANGUARD CAPITAL MANAGEMENT LLC22.12M1.44M+6.98%782.94M
VANGUARD PORTFOLIO MANAGEMENT LLC21.64M1.80M+9.09%765.89M
GOLDMAN SACHS GROUP INC18.56M7.44M+67.00%656.71M
STATE STREET CORP17.80M1.61M+9.94%629.80M
UBS GROUP AG17.47M-5.15M-22.78%618.14M
FARALLON CAPITAL MANAGEMENT, L.L.C.14.31M4.63M+47.90%506.40M
GEODE CAPITAL MANAGEMENT, LLC11.67M1.49M+14.65%425.54M
ADAGE CAPITAL PARTNERS GP, L.L.C.10.35M-2.44M-19.11%366.26M
WELLS FARGO & COMPANY/MN9.60M9.60MNew339.74M
TWO SEAS CAPITAL LP8.48M7.74M+1057.36%299.94M
ASSENAGON ASSET MANAGEMENT S.A.8.36M1.29M+18.18%295.96M
PERCEPTIVE ADVISORS LLC8.09M-200.00K-2.41%286.14M
PATIENT SQUARE CAPITAL LP8.02M-145.12K-1.78%283.86M
INVESCO LTD.7.53M1.09M+16.96%266.53M
JANE STREET GROUP, LLC7.29M6.26M+613.76%257.83M
DARWIN GLOBAL MANAGEMENT, LTD.6.75M-50.00K-0.74%234.33M
AQR CAPITAL MANAGEMENT LLC6.63M686.70K+11.55%234.03M
VIKING GLOBAL INVESTORS LP6.27M-380.98K-5.73%221.95M
RUBRIC CAPITAL MANAGEMENT LP6.00M1.00M+20.00%212.34M
CITADEL ADVISORS LLC5.58M3.06M+121.63%197.34M
DIMENSIONAL FUND ADVISORS LP5.23M-2.25M-30.04%185.06M

Forecast

Consensus Buy from 14 analysts. Average price target $47.71, +26.6% versus the current price. Low $41.00. High $55.00.

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Analysts have an average 12-month price target of $47.71 for Roivant Sciences (ROIV), 26.4% above the current price of $37.75. Of 14 analysts covering the stock, 12 rate it Buy or Strong Buy, 2 Hold, and 0 Sell or Strong Sell, giving a consensus of Buy.

Forecasts are third-party estimates and often wrong. They are not investment advice.

ROIV price target

12-month price target
Low$41.00
Average$47.71
High$55.00

The average is 26.4% above the current price of $37.75.

Is Roivant Sciences a buy or sell?

Of 14 analysts, 12 rate Roivant Sciences Buy or Strong Buy, 2 Hold, and 0 Sell or Strong Sell. The consensus label is Buy. That split is not a recommendation.

Roivant Sciences earnings and revenue forecast

Analyst averages on file: 2026, EPS -1.12, revenue $9.09 million. 2027, EPS -1.38, revenue $52.10 million.

ROIV score and fair value

The Stocklytics Score for ROIV is 35 out of 100. It averages value, quality, and growth against a large-cap US universe. It is not a price target and not a buy or sell rating. Fair value is a separate estimate on the fair value tab.

ROIV forecast FAQs

What is the ROIV price target?

$47.71 average, with a published range of $41.00 to $55.00.

Is Roivant Sciences a buy or sell?

The consensus is Buy from 14 analysts. This is not a recommendation.

What is the Roivant Sciences stock forecast for 2026?

Analysts' average EPS estimate for 2026 on file is -1.12. The average revenue estimate is $9.09 million.

What will ROIV be worth in 2030?

No reliable forecast exists that far out.

When is Roivant Sciences's next earnings report?

The next earnings date is shown on the stock page when a future report is on the calendar. This forecast does not invent a date.

Related: Roivant Sciences · Financials · Dividends · Compare · AI stocks

Capital is at risk. Stocklytics is operated by Stocklytics Inc., a Marshall Islands company. It is not regulated by the FCA and does not give investment advice.

Roivant Sciences (ROIV) Stock Forecast & Price Target

ROIV$37.69+0.57 +1.55%

$27.22B

Market Cap

-97.66

P/E

28.17

Forward P/E

35

Score

Price History